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Abstract 
The paper discusses the characteristics of healthcare supply chains, and puts particular emphasis on 
the implementation of VMI/CMI in this sector specific context. By the means of case study research 
the paper provides empirical data on the benefits of the above collaborative practices for both the 
hospital and vendors. The paper contributes to the stream of research on VMI/CMI in the healthcare 
sector, where limited research attempts have been conducted so far. In contrast to other surveys this 
case study shows that specific and measurable cost reductions exist, in addition to other 
improvements such as better control over the inventories, and also in reduction of administrative 
work. Results obtained may be also relevant to other hospitals and vendors and as they can form a 
basis for comparisons. 
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1. Introduction  
The healthcare sector is facing major challenges nowadays. Healthcare providers and institutions are 
under an increasing pressure to deal with a number of inefficiencies, in order to achieve an optimum 
balance between improvements in quality healthcare services and cost effectiveness (Norris, 2002, Di 
Martinelly, Riane, and Guinet, 2009; Dillon and Prokesch, 2010). Supply chain costs can account for 
over one-quarter of a hospital’s operating budget, while the healthcare industry could significantly 
improve its ability to deliver quality healthcare products and services to consumers and save as much 
as $11 billion (CSC Consulting, 1996). Many authors (Towill, and Christopher 2005; Schneller and 
Smeltzer, 2006, de Vries, 2011; Min, 2012), have pointed out that saving opportunities are not 
currently exploited by organizations due to supply chain inefficiencies, such as ineffective inventory 
control and materials management, inadequate purchasing orders, and distortion of information flows 
involved in the transport and delivery of supplies to the healthcare providers.  
 
A key problem creating these inefficiencies is the lack of collaboration among healthcare entities. 
Collaboration at various levels in the chain has been recognised as a way to construct ever more efficient 
and responsive supply chains, in order to deliver exceptional value to customers (Matopoulos et al., 2007). 
Examples of collaborative practices are Vendor Managed Inventory (VMI) or Co-Managed Inventory 
(CMI), which is a variation of VMI. In the literature a plethora of studies exist, particularly for the VMI 
practice. For example, Chatzipanagioti, Theodori, and Vlachos, (2007) compared VMI system 
performance to traditional retailer managed inventory discussing also the technological infrastructure 
required. In a similar vein Zhang, Zhang and Guo (2008, p. 91), compared the performance of VMI 
with the performance of decentralised inventory policy suggesting that: “under a certain cost 
condition, although VMI likely reduces the vendor's profit, it, compared with decentralised inventory 
policy, will decrease the retail price and consequently brings higher expected profit level for the buyer 
and the whole supply chain”. Borade and Bansod (2012) presented the differences in the 
implementation of VMI practices between the manufacturing and the services sectors. Many studies 
have also taken place in other sectors such as the automotive or the electronics, but only a few 
studies have been conducted in the context of the healthcare sector. Against this background, the aim 
of this paper is twofold: to increase the understanding of the nature of collaborative practices in 
healthcare supply chains and to provide empirical evidence on the impact of hospital-vendor 
collaborative practices by comparing reported and actual outcomes related to these practices. More 
specifically we try to answer the following research questions: 
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- RQ1. What is the real impact of the implementation of CMI? 
- RQ2. What are the factors enabling the implementation of such practices in a hospital 
environment? 
 
The rest of the paper is structured as follows. In the next section, the specific characteristics of the 
healthcare chain are discussed so as to provide an understanding of the complexities of the sector. 
Next, an analysis of the characteristics, benefits, and requirements of VMI/CMI is provided. Finally, 
the case study is presented and the findings and their implications are discussed. 
 
2. Healthcare supply chains   
The healthcare supply chain shares a number of similarities with other chains, not only in terms of 
processes (e.g. procurement, warehousing, distribution), but also in terms of discerning customers 
and management structures (Walters and Rainbird, 2007). There are also differences in the chain that 
are related to the specific characteristics and requirements of the sector. In general, healthcare supply 
chains are very complex, diverse, and dynamic. That complexity arises from the numerous companies 
and organizations participating in the chain, which are involved in many interactions across the entire 
chain. Burns and Wharton School Colleagues (2002), provided an extensive presentation of 
healthcare entities by grouping organizations performing similar tasks. They proposed five major 
groups of entities: payers (e.g. government, employers, or any other individuals), fiscal intermediaries 
(e.g. insurance companies, health maintenance organizations, pharmacy benefit managers), 
providers (e.g. hospitals, divisions, physicians, and facilities such as physician offices, medical and 
ambulatory surgical centres and pharmacies), purchasers (e.g. resellers such as pharmaceutical 
wholesalers, medical surgical distributors, product representatives, independent contracted 
distributors, group purchasing organizations) and producers (e.g. pharmaceutical manufacturers, 
medical device manufacturers, medical surgical manufacturers, providers of information technology 
services and manufacturer of capital equipment). In addition, many different processes, tasks, 
intermediaries, and interfaces take place in each entity.  
 
Much of this complexity is also related to the focal entity, the hospital and the numerous internal 
independent divisions/departments, pharmacy store(s), and hospital staff. It is worth noting that the 
hospital management has limited possibilities to control production as it is driven by medical 
specialists who, nevertheless, do not manage that process (Vissers, Bertrand, and de Vries, 2001). 
Hospital staff is often responsible for adding complexity and inefficiency in the healthcare system. For 
example, as Kelle, Woosley, and Schneider (2012) argue the decisions on the prescribed drugs by 
physicians, pharmacists/pharmacy directors are not always well aligned due to their specific "product 
preferences". This situation is causing excessive variability, huge product portfolio ranges and 
minimizes the possibilities for stock reduction, improved inventory control and streamlined purchase 
practices. Diversity arises, as a result of the differences among the organizations or the individuals 
involved, in terms of human and financial capital, as well as processes followed and departmental or 
unit goals. In many occasions, different departments or divisions or even different people within the 
same healthcare system, have different value drivers or even different goals.  
 
Differences occur as a result of the distinct healthcare service or product characteristics and 
respective physician or management practices. Similar to Fisher’s (1997) suggestions on the need for 
adopting multiple supply chain designs, Towill and Christopher (2005) argue that some treatments 
such as hernia repairs need dedicated pipelines (“lean” operations, focusing on waste removals) 
whereas others need to be more broadly based and responsive, hence the need for agility (time 
sensitivity and flexibility). Mustaffa and Potter, (2009) refer also to distinctive characteristics in the 
distribution part of the chain, particularly from the wholesaler to the hospital namely: shrinking product 
lifecycles, small operating profit margins, forecasting difficulties and lack of supply chain education.  
 
In terms of product differences and based on the categorization proposed by Singh (2006) and by the 
Greek Ministry of Health and Social Solidarity (3580/2007 Law) the following distinct supply chains, in 
terms of supplies, can be identified: Pharmaceutical, Medical-Surgical supplies, Medical Devices, 
Health Aids (e.g. bandage, syringe), Office supplies (e.g. printer cartridges, print paper) and Clothing 
supplies (e.g. uniform, sheets, towels). Each group of supplies has specific constraints, and is 
triggered by different demand patterns. There are other flows that often cut across entire national 
healthcare systems. The blood or transplant supply chains for example, from donors to patients, may 
include collection, testing, production/processing, storage and transportation to various hospitals and 
3 
 
health care centres wards and operating rooms (Rytila and Spens, 2006). Finally, the dynamic 
character of that chain could be explained by the very “uncertain” nature of the sector related to 
difficulties in predicting medical, blood and pharmaceuticals supply and consumption, but also due to 
policy changes (Mustaffa and Potter, 2009; Samuel et al. 2010). Demand characteristics require 
healthcare organizations to be both efficient (in the case of products with predictable demand) and 
responsive (in the case of transplants, pharmaceuticals, medical and surgical supplies with an 
unpredictable demand). The number of products and relevant demand of those products varies 
greatly from one patient care unit to the other. Against this background, demonstrating the benefits 
emanating from building collaborative relationships within the entire healthcare chain becomes a 
necessity and this is the focus of this paper.  
 
 
3. Collaborative practices in the healthcare sector   
VMI / CMI are forms of co-operation between a vendor and a customer originated more than two 
decades ago in the grocery industry aiming to achieve performance improvements in the 
management of inventories. In the following paragraphs, a presentation of the expected benefits and 
requirements are provided, as well as specific insights and issues arising from VMI/CMI 
implementation in the healthcare sector. 
 
3.1. Characteristics, benefits and requirements 
The basic idea of VMI/CMI is that the vendor manages and takes full (VMI) or joint (CMI) responsibility 
for inventories. The fundamental difference between CMI and VMI is that the customer maintains 
responsibility for the replenishment in CMI by revising and confirming proposed orders while this 
responsibility is transferred to the supplier in VMI under the control of a pre-established agreement. In 
both cases the customer and the supplier share inventory and sales related information, which are 
transmitted from the customer to the vendor who then executes stock replenishment or forecasts data 
for future stock requirements. According to Kaipia, Holmstrom, and Tanskanen (2002), the 
fundamental change in these practices is that the ordering phase of replenishment is abolished, giving 
to supplier both authority and responsibility to take care of the entire process. Similarly, Vigtil (2007), 
describes VMI as: “an untraditional concept of allocation of responsibility in the replenishment 
process”. In terms of benefits, such collaborative practices can increase the overall supply chain 
performance by decreasing inventory levels, improving customer service levels, reducing order cycle 
and increasing fill rates (Waller, Johnson, and Davis, 1999; Cachon and Fisher, 2000; Yugang, Liang, 
and Huang, 2006; Yao et al., 2007).  
 
Reducing inventory levels in healthcare is critical as inventories are one of the major sources of 
inefficient allocation of financial and human resources. Hospitals tie up as much as one third of their 
budgets in inventory and the required labour to manage it (Oliveira and Nightingale, 2007). 
Surprisingly, nursing shortages is also an issue related to inventories, since nurses sometimes take 
decisions on inventory levels, instead of providing their services to patients. Inventory management 
could represent a major source of inefficiency which could be potentially reduced by using VMI/CMI. 
This is becoming very common in many healthcare systems. In Greece, hospitals are facing an 
estimated nursing shortage (approx. 6.000 nurses), while in the United States, the nursing shortage 
will reach 600.000 by 2020 (Oliveira and Nightingale, 2007).  
 
VMI/CMI is very likely to confront one of the more important inefficiencies in the healthcare sector, the 
existence of secret inventory stashes. Many physicians, nurses of even heads of departments or 
clinics tend to maintain higher and “secret” inventories, in order to avoid stock-outs. Lee and Chu 
(2005) argue that the shift of the responsibility for inventory-carrying and replenishing from the 
customer to the supplier is expected to create an extra burden for the supplier; thus, most of the 
proposed benefits of VMI/CMI implementation are more likely to be realized by downstream supply 
chain members notwithstanding that the VMI/CMI implementation is beneficial for the supplier. For 
example, it gives the supplier more time to react, it brings benefits in the production planning process 
and in inventory management, it minimizes lost sales and finally, it improves delivery service in 
supplier’s customers not engaged with VMI (Kaipia, Holmstrom, and Tanskanen, 2002; Lee and Chu, 
2005; Kaipia, 2008; Mustaffa and Potter, 2009). Table 1 provides a brief presentation of the benefits 
of VMI/CMI. 
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Table 1: VMI / CMI benefits  
VMI / CMI benefits
For the Customer For the Vendor 
Reduces or eliminates purchasing activities and 
wasted time in non value added processes 
Improved visibility of customer demand enabling the 
supplier to postpone manufacturing or to postpone 
other decisions (e.g. purchasing stock)  
Enables focus on strategic supplier management 
and process development  
Improved visibility translates to added flexibility in 
production scheduling  
Reduces or eliminates order backlog  Improvements in the distribution process (increase 
transportation efficiency) 
Improvements in inventory turnover and reductions 
in stock outs  
Enables the provision of increased levels of  service to 
the customer 
 
 
3.2 Implementing VMI/CMI in the healthcare sector: A research framework 
Despite the expected benefits and results reported in several cases, VMI/CMI implementation is a 
demanding task (Kaipia, Holmstrom, and Tanskanen, 2002) and Muckstadt et al. (2001) comment that 
the actual results of VMI/CMI implementations are often disappointing. What are the reasons for this? 
First of all, both the vendor and the customer may be unwilling to share information or may be incapable 
of doing so as a result of incompatible information systems. Lack of trust represents an additional 
constraint factor for the implementation of VMI/CMI practices (Danese, 2006). The healthcare sector is 
also facing quite distinct inventory-related problems, which add complexity in the VMI/CMI 
implementation making thus the realization of benefits a demanding and difficult task. A stock-out in a 
hospital pharmacy is not at all comparable to a stock-out in a retailing store and the responsibility of 
replenishment is much critical in that chain.  
 
This has been proved to be a very important reason in our case study that has driven the hospital under 
research to implement the CMI practice instead of VMI. Limited research has been reported for the 
implementation of VMI/CMI in the healthcare sector, particularly for its adoption. For example, Oliveira 
and Nightingale (2007) emphasized the relationships of two hospitals in the US healthcare with a 
leading healthcare vendor and indicated significant improvements in areas such as product 
availability, data visibility and labour use reduction for inventory management. Another successful VMI 
implementation was reported by Tsui et al. (2007) in an Australian hospital. Despite an initial surge of 
stock holding, the one-off savings from stock reduction was maintained 18 months after 
implementation. However, it was found that manufacturers have lagged behind in-fill rates compared 
to wholesalers. Improved data exchange between wholesalers and manufacturers was expected to 
reduce stock holding across the entire supply chain. Another study by Claasen et al. (2008) showed 
that purchasing managers who invest in the relationship with the supplier and have a good IT 
infrastructure are more likely to get better results from a VMI implementation. Furthermore, the study 
revealed that VMI is often implemented with wrong expectations about the benefits: most managers 
expect major cost reductions when implementing VMI. Instead, VMI often results in some cost 
reductions but benefits can be expected from improved service levels and improved supply chain 
control. In another recent survey by Bhakoo, Singh, and Sohal, (2012) it was found that collaborative 
arrangements and respective perceived benefits amongst supply chain partners can vary significantly 
due to several contingent factors such as: product characteristics, spatial complexity, regulatory 
environment, goal congruence and degree of trust/commitment between organisations and physical 
attributes (e.g. hospital’s size, availability of storage space, stage of IT adoption). 
 
Based on the previous analysis and particularly the work by Claasen et al. (2008) and by Bhakoo, 
Singh, and Sohal, (2012) the following framework was developed (Figure 1). The framework links 
vendor’s-hospital’s perceived CMI impact with the forces affecting its implementation. The forces have 
been classified to extra-organizational ones and intra-organizational ones. Extra-organizational forces 
include those that are not related directly to the hospital such as: external pressures, relationship 
quality, and vendor’s capability. The external pressures include pressures from the government or the 
competition, which could act as a catalyst in implementing the VMI/CMI practices. Relationship quality 
is related to the actual ability to collaborate with the suppliers, by exchanging and sharing information 
with trust and without the fear of facing opportunistic behaviour. Vendor’s capability is related to 
readiness and availability to provide such a service to the hospital. Intra-organizational forces include 
the capability to recognize potential benefits and the ICT capacity which will facilitate the control of 
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inventories. Finally, operational capacity is related to changes and adjustments that are needed to 
streamline the implementation process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: A conceptual framework of forces affecting implementation and impact of VMI/CMI 
 
4. Research Context & Method  
4.1 An overview of the Greek healthcare supply chain  
The Greek healthcare supply chain (GHSC) is characterized by increased complexity and it is quite 
fragmented. In terms of finance, following the European taxonomy of health systems, Greece 
presents a mixture of public contract and public integrated models financed by a mixture of social 
insurance contributions, general taxation, and private payments (Yfantopoulos, 2007). Essentially, 
patients finance the system both directly (charges, private insurance contribution) and indirectly 
(taxation). It is estimated that 10% of the GDP (more than the European average) is allocated making 
Greece the first country in Europe and the second in OECD countries in terms of expenditures 
(Yfantopoulos, 2007). In terms of healthcare facilities, 340 hospitals exist with 40% of them being 
public, but holding 70% of national bed capacity. Public hospitals and National Health Service (NHS) 
facilities (e.g. regional clinics), are provided with hospital supplies by more than one thousand 
companies. It is estimated that there is a range of around 500.000 medical products currently in the 
GHSC. In terms of medicines, nearly 11.000 different products exist and nearly 40% of the annual 
NHS budget is allocated to medicine supplies (Ygeianet, 2007). The vast majority of these products is 
produced by 70 pharmaceutical companies, and then are distributed by a network of private (112 
companies) and other distributors (27 companies). In fact, Greece has one of the biggest numbers of 
pharmaceutical wholesalers (GIPR, 2004; IPF, 2005). Figure 2 provides a schematic representation of 
the Greek healthcare supply chain. 
 
 
Figure 2: A schematic representation of the Greek healthcare supply chain 
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The Greek healthcare sector has recently been under a significant pressure to become competitive 
and particularly cost effective. Greece has enjoyed a national health care system since 1983 
(1397/1983 Law). The Greek health care sector remains highly centralised with the Ministry of Health 
& Welfare exercising control and supervision over all aspects of health care. Since 1983, several 
reforms were applied in the system rather unsuccessfully. The 2001 reform established regional 
health care systems aiming to provide health care policies for their regions, map local population 
needs, decide upon the establishment of new hospital departments and their potential merging or 
closure, determine human resource needs, authorise health care services and budgets, supervise 
supplies and commissions for health care services and develop qualitative and quantitative indicators 
to measure the effectiveness of health care services (2889/2001 Law) (Tountas, Karnakis, and Pavi, 
2002; Michailidou, 2003). The latest reform took place in 2007 (3580/2007 Law) where the focus is on 
achieving performance improvements in the healthcare supply chain by managing inventories better. 
According that reform, a new Procurement Committee is established which will have responsibility for 
planning procurement practices and inventory controls across the entire Greek NHS. This new 
initiative is expected to put an end in a procurement and logistics system of autonomy, anarchy and 
inefficiency and to streamline the respective operations. According to the Greek Ministry for Health 
and Welfare, each year nearly 300 NHS institutions conduct 10.000 calls for hospital supplies 
suggesting that the implementation of any practices or initiatives (such as VMI/CMI) can be critical.    
 
4.2 Research method  
We chose the case study method in this research and specifically the “single case design” (Yin, 1994) 
with multiple units of analysis. This method was preferred since it enables a more descriptive and 
exploratory approach allowing for more rich insights into the research object (Yin, 1994; Miles and 
Huberman, 1994). In order to collect data, an interview protocol has been developed which linked the 
questions to the issues identified in the literature (see Appendix). In particular, the first part of the 
interview protocol included questions regarding the hospital and distinct characteristics in terms of 
hospital supplies, replenishment and order strategies followed. The second part dealt with the 
relationship between the cardiology department (the unit of angioplasty in particular), and the vendors 
which are currently collaborating with the inventory management processes. In this part, a number of 
issues regarding benefits, obstacles and evolution of relationships were explored. The same interview 
protocol (after adaptation) was used for interviews with two vendors. The use of collaborative 
practices with vendors is not rare in a hospital. A number of departments/units such as neurosurgery, 
orthopaedic surgery, plastic surgery, ophthalmology, in addition to angioplasty have put in place 
similar practices.  
 
However, in this research emphasis is placed on the angioplasty unit from the cardiology department, 
where supplies have very short life and are of high value. It was also decided not to examine VMI/CMI 
practices for drugs for two reasons: first of all, most drugs do not have as short life as other supplies, 
thus there is no danger for them to expire. Secondly, on average, most drug prices are significantly 
lower in comparison to other supplies. In total, five people were interviewed. More specifically, at 
hospital level, three semi-structured in depth interviews took place with one warehouse manager and 
one procurement manager of the cardiology department. The initial analysis of the data shows that 
there was some lack of understanding regarding the financial benefits of VMI/CMI, which resulted in 
an additional interview with the director of finance in order to provide additional financial evidence and 
estimations. At the vendors’ side, interviews took place with two managers of two vendors dealing 
with the most critical supplies in diagnostic and interventional cardiology such as endeavour sprints, 
balloon dilatation catheters, coronary guiding catheters, and coronary guide wires. The duration of all 
interviews was less than an hour and these were conducted during three visits to the hospital and two 
visits in vendors’ offices. The hospital was selected based on three basic criteria: firstly, it was the 
size of the hospital. A big hospital was selected having 2.000 staff, a capacity of 800 beds, and 
various activities. The hospital is made up of numerous clinics in medical areas such as renal and 
haemodialysis, oncology, inpatients surgery, neurology, rheumatology and dermatology and makes 
use of the latest specialist equipment. An ERP system was installed and this would facilitate the data 
collection and exchange.  
 
The second criterion was related to the legal character of the hospital. The hospital represents the 
country’s largest legal entity of private law in health care, operates under the control of the Ministry 
and is managed by nine board members. It was expected that this non-public hospital would be more 
motivated to follow current management practices in order to achieve performance improvements. 
The last criterion was data accessibility. In Greece, companies are hesitant to participate in surveys 
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for confidential topics such as procurement and cost. Vendors, on the other hand, were selected on 
the basis of their experience in CMI and their close relationship with the hospital in terms of order 
volume and order value in the unit of angioplasty. The first vendor was founded in 1958 and it 
represents one of the most reliable, reputable and innovative business specialising in the cardiology, 
cardiac surgery, vascular surgery and interventional radiology fields. The company has offices in 
Athens and Thessaloniki, it has 63 employees, and it applies a thorough quality certification system. 
The other vendor was founded in 1978 and possesses 20% of the Greek market representing foreign 
Houses for import and sale of hospital equipment. The main medical equipment that the company 
imports and exclusively distributes includes heart pacemakers, heart valves, angioplasty material, 
arterial grafts, cardiac catheters, and cardiac surgery material. Staff comprises 60 people and its 
headquarters are located in Thessaloniki. 
 
5. Empirical Findings 
5.1 Understanding the complexity of hospital operations 
Table 2 presents the five major categories of hospital supplies such as Health Aids (e.g. bandage, 
syringe), Medical Devices, Medical-Surgical supplies, Office supplies (e.g. printer cartridges, print 
paper), and Clothing supplies (e.g. uniform, sheets, towels). For each category, data are provided in 
relation to various product related aspects such as product portfolio range (number of different items), 
cost contribution of each product category (as a percentage of total procurement expenditures), 
delivery frequency, no of suppliers (size of supplier base), lead time (days needed from order until 
order receipt), inventory management (what is the strategy followed for replenishment), distribution 
tactics followed (directly from supplier to department or unit, first delivered to the central warehouse of 
the hospital) and replenishment control and decision (who is responsible for control and setting the 
order). In Table 2, no evidence for drugs is given and it was decided to avoid variety and complexity.  
 
Table 2: Hospital supplies and distinct characteristics 
Product aspects   Broad categories of Hospital supplies 
Health aids Medical devices Medical- 
Surgical supplies 
Office supplies Clothing  
supplies 
Product portfolio 
range 1.000 100 18.000 200 10 
Cost contribution    23% 5% 70% 1% 1% 
Delivery frequency Once a week Once or twice a year Every day Once a year Once a year 
Suppliers’ base 15 3 30 2 2 
Lead time   1-5 days 1-20 days 1-3 days 1-5 days 1-15 days 
Inventory 
management   
Periodic review & 
replenishment 
Periodic review 
& replenishment
Periodic review & 
replenishment
Periodic review 
& replenishment 
Periodic review & 
replenishment
Distribution tactic  Hospital’s central warehouse  
Hospital’s central 
warehouse 
Hospital’s central 
warehouse 
Hospital’s central 
warehouse 
Hospital’s central 
warehouse 
Replenishment 
control & decision Centralized  
Decentralized 
(departments)
Decentralized 
(departments) Centralized Centralized 
 
 
5.2 CMI adoption, implementation and benefits 
The unit of angioplasty (cardiology department) was the first one to adopt CMI. It has a product 
portfolio range of approximately 320 items, most having high value and short life; hence, the decision 
to implement CMI for nearly 40% of the products was not a difficult one. CMI was implemented jointly 
with consignment enabling the hospital to be charged only for the materials actually used. For the 
hospital, the main reason for the adoption of CMI was reduction of expenditures on medical supplies 
as there were many cases of overstocking by departments. The finance director stated: “At the 
opening of the hospital we followed the inventory levels of another similar public hospital of the same 
size and structure…that resulted in excessive overstocking of some supplies”. The vendors are 
visiting the department very frequently and control the level of inventories, as well as the expired 
dates. In particular, the vendors are informing the department employees for those products that are 
close to expire. According to the first interviewee from the cardiology department: “we have adopted 
this policy the last three years and we are now better off in inventory control and we have achieved 
reductions in administrative work spent in monitoring the warehouse”. Regarding potential reduction 
of stock outs the second interviewee stated: “stock-outs were never a problem in our unit… but what 
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we did achieve to reduce was overstocking”. Regarding the financial benefits for the hospital, followed 
the implementation of CMI, the director of finance mentioned: “CMI resulted in direct financial 
benefits, such as a reduction in the number of expired supplies, but also indirect benefits such as 
wasted working hours of the personnel or capital savings, which are invested elsewhere in the 
hospital…approximately 10% savings per year in comparison to the past”. He continued: “in the past, 
we used to place big orders to our vendors which often led to many goods that would expire before 
use”. Table 3 presents CMI implementation at the angioplasty unit. 
 
Table 3: CMI implementation in the angioplasty unit at a glance 
Angioplasty Unit Figures
Key elements 
Product portfolio range 320 
Products under CMI    40% 
Cost range of the products under CMI 160-2500 € (per item) 
Years of CMI in practice 3 
Number of Vendors in CMI 10 
Annual Financial benefits   
(for a 10 m. € order) 
10% 
- 1% (savings in employee  salaries for  those managing inventories)
- 3% (savings from expired goods) 
- 6% (from opportunity costs) 
 
On the other hand, there are some problems in the CMI implementation. One of the first problems 
reported is that vendors are not very reliable in their visits and often they do not follow visit time 
windows. An additional problem is that some vendors tend to overstock for some supplies. This is a 
paradox since the hospital is going to be charged only for the supplies that have been used. A 
potential explanation is that vendor’s salesmen tend to overstock some supplies either to completely 
eliminate the out-of-stock possibility or to meet sales targets in specific months or periods. According 
to the director of finance: “overstocking by vendors takes place in order to avoid delays caused by the 
bureaucratic hospital machine when placing orders”. The interviews with managers from vendors 
revealed that most of the benefits reported in the literature are true. For example, both vendors 
mentioned that CMI enables them to have a better control of their distribution, warehouses, and 
suppliers and also provides them with the opportunity to develop more close relationships with their 
customers (the hospital). In terms of difficulties in the implementation of CMI, it is reported that most 
of them emanate from inefficient information sharing processes and the bureaucracy in hospital 
processes. According to one interviewee (vendor): “one of the most important problems we face is 
that our client [hospital] often places urgent orders! That is due to drawbacks of the hospital internal 
order system. It takes many approvals and many signatures for an order to get placed. We can do 
nothing but satisfy our customer the way he wants it even if they call us in the middle of the night…”. 
 
 
6. Conclusions 
This paper examined the healthcare supply chain and discussed the collaborative practices currently 
in place. In an era where many healthcare systems in the word are under major critique, 
understanding the complexity of the system is the first step towards improvement. The paper initially 
attempted to provide an analysis of the characteristics of the healthcare supply chain and identified 
sources of complexity and diversity. In particular, the study provided empirical insights from hospital 
operations. For example, in terms of complexity, five major categories of supplies were identified in 
the hospital environment with significant differences in terms of product portfolio range, cost 
contribution, delivery frequency patterns, size of supplier base, lead time, inventory management and 
distribution tactics and replenishment control and decision. The paper provided also insights following 
the CMI implementation in a Greek hospital. With increased cost competitiveness, the hospitals have 
to look at some practices that could improve their performance. Interviews revealed that significant 
financial and operational benefits exist for both hospital and vendors. The survey by Claasen et al. 
(2008) suggested that cost reduction is not the most salient benefit of a VMI implementation, but 
benefits should be sought primarily in service levels and improved supply chain control. In contrast to 
this survey, this case study showed that for the hospital, there are specific and measurable cost 
reductions on top of other improvements such as better control over inventories. From a managerial 
point of view we believe that this paper offers some interesting insights to hospital managers on 
identifying areas where potential benefits exist and can be captured with rather limited investment.  
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In terms of limitations, this study was explorative in nature drawing from a single case study, thus the 
ability to generalise the findings is limited. Also, the vendors that took part in this research were the 
ones that agreed and as a result the views of a number of other vendors who did not agree to take 
part in this research are not taken into consideration. Despite these limitations we believe that these 
preliminary results provide useful insights and explanations that could be helpful to other researchers 
involved in the understanding of the healthcare supply chain and the uptake of such collaborative 
practices in hospitals. Not many similar surveys have taken place and we believe that this paper 
contributes in the body of research by providing rich empirical data. Results obtained may be also 
relevant to other hospitals and vendors and can form a basis for comparisons. The study could 
motivate health policy decision makers in order to move towards more effective management 
methods. Future research should try to further confirm or not the findings of this paper in the context 
of other hospital departments and units. For example, it would be interested to address whether and 
how the factors proposed in the conceptual framework affect CMI implementation and benefits in 
other units. Similarly, it is worth investigating whether or not the benefits of CMI implementation are 
equally shared among hospitals and vendors and also what are the strategies that could be used to 
convince vendors in taking part in similar initiatives. 
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Appendix: Interview protocol  
A.1 Overview 
A.1.1 General Hospital information 
1. Size of the Hospital (number of employees, bed capacity) 
2. Department and units of the hospital 
3. Describe the current basic functions of the hospital (e.g. activities outsourced) 
 
A.1.2 Hospital operations and characteristics 
1. Describe the challenges that the healthcare sector is facing 
2. What are the major weaknesses in terms of operations that the hospital is facing? 
 3. What are the immediate of future action that you are thinking of undertaking to improve your 
performance?  
 
A.1.3 Warehouse and inventory management  
1. Which are the major product categories in your warehouse, and which are the challenges and 
problems you face in managing them? 
2. What are the characteristics of each product category in term of supplier’s base, demand and order 
patterns?  
3. What is the inventory management, distribution, replenishment strategy followed for each product 
category? 
 
A.2 VMI implementation 
A.2.1 General characteristics of the department 
1. Describe your department in terms of product portfolio range, product characteristics etc. 
2. Motivation for implementing VMI?  
3. What was the extent of VMI implementation? 
 
A.2.2 Benefits and problems in VMI implementation 
1. Describe the key benefits as a result of VMI implementation?  
2. What were the main problems encountered in establishing VMI (e.g. operational changes, ICT 
requirements etc)? 
3. Provide a comparison to previous non VMI status 
 
A.2.3 Analyse the relationship with vendors 
1. Discuss the evolution of relationships with vendors?  
2. What are the most common sources of conflicts with vendors? 
 
